CircSEMA4B inhibits the progression of breast cancer by encoding a novel protein SEMA4B-211aa and regulating AKT phosphorylation

CircSEMA4B inhibits the progression of breast cancer by encoding a novel protein SEMA4B-211aa and regulating AKT phosphorylation

Abstract PI3K/AKT signaling pathway plays an important role in regulating the tumorigenesis, recurrence, and metastasis of breast cancer (BC). In this study, we discovered a circRNA with protein-coding potential, which we named circSEMA4B. CircSEMA4B could encode a novel protein, SEMA4B-211aa. Both...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Xuehui Wang, Wei Jian, Qifeng Luo, Lin Fang
Fformat:	Erthygl
Iaith:	English
Cyhoeddwyd:	Nature Publishing Group 2022-09-01
Cyfres:	Cell Death and Disease
Mynediad Ar-lein:	https://doi.org/10.1038/s41419-022-05246-1

Eitemau Tebyg

CircSEMA6A upregulates PRRG4 by targeting MiR-520h and recruiting ELAVL1 to affect cell invasion and migration in papillary thyroid carcinoma
gan: Yachao Liu, et al.
Cyhoeddwyd: (2024-06-01)

Roles of Sema4D and Plexin-B1 in tumor progression
gan: Kumanogoh Atsushi, et al.
Cyhoeddwyd: (2010-09-01)

Sema6B, Sema6C, and Sema6D expression and function during mammalian retinal development.
gan: Ryota L Matsuoka, et al.
Cyhoeddwyd: (2013-01-01)

SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling
gan: Lu Liu, et al.
Cyhoeddwyd: (2022-07-01)

The sema domain.
gan: Gherardi, E, et al.
Cyhoeddwyd: (2004)

Zonisamide‐responsive myoclonus in SEMA6B‐associated progressive myoclonic epilepsy
gan: Rebecca Herzog, et al.
Cyhoeddwyd: (2021-07-01)

Inhibition of Sema4D/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy
gan: Jie‐hong Wu, et al.
Cyhoeddwyd: (2020-01-01)

Hüccetü’s-Semâ’ XVII. Yüzyıl Osmanlı Toplumunda Mûsikî, Semâ’ ve Devran Hakkındaki Dînî Tartışmalar ve İsmâil Ankaravî’nin semâ’ müdâfaası
gan: İsmâil Ankaravî, et al.
Cyhoeddwyd: (2007-12-01)

The performance analysis of SEMA system
gan: LI Li-chun, et al.
Cyhoeddwyd: (2003-01-01)

The performance analysis of SEMA system
gan: LI Li-chun, et al.
Cyhoeddwyd: (2003-01-01)

The Interaction of Status and Appraisive Semas
gan: T D Podyakova
Cyhoeddwyd: (2013-12-01)

Hazîn-i Lâhîcî’nin Fevâidü’s-Semâ’ Adlı Eseri ve Semâ’a Bakışı
gan: Seyid Muhammed Taki Hüseyni, et al.
Cyhoeddwyd: (2021-12-01)

Correspondence: SEMA4A variation and risk of colorectal cancer
gan: Ben Kinnersley, et al.
Cyhoeddwyd: (2016-03-01)

A Sema3C Mutant Resistant to Cleavage by Furin (FR-Sema3C) Inhibits Choroidal Neovascularization.
gan: Shira Toledano, et al.
Cyhoeddwyd: (2016-01-01)

A Pilot Study of the Role of Semaphorin 4A (sema4A) and 3C (sema3C) in Non-Muscle-Invasive Bladder Cancer (NMIBC)
gan: Piotr Purpurowicz, et al.
Cyhoeddwyd: (2024-10-01)

Semaphorin-4D (Sema-4D), the Plexin-B1 ligand, is involved in mouse ovary follicular development
gan: Goldman Shlomit, et al.
Cyhoeddwyd: (2007-03-01)

Correspondence: Reply to ‘SEMA4A variation and risk of colorectal cancer’
gan: Heinz Sill, et al.
Cyhoeddwyd: (2016-03-01)

Ecstasy in Music: The Case of Sema and Semah
gan: Merve Nur Kaptan
Cyhoeddwyd: (2024-06-01)

FORMAL ANALYSIS OF “SEMA-I MEVLÂNÂ”
gan: Mümtaz Sarıçiçek
Cyhoeddwyd: (2014-08-01)

Sema4D silencing increases the sensitivity of nivolumab to B16-F10 resistant melanoma via inhibiting the PI3K/AKT signaling pathway
gan: Zhuo Zhang, et al.
Cyhoeddwyd: (2023-04-01)

<i>SEMA6B</i>-related progressive myoclonus epilepsy in a patient with Klinefelter syndrome
gan: T. V. Kozhanova, et al.
Cyhoeddwyd: (2024-04-01)

Progressive myoclonus epilepsies due to SEMA6B mutations. New variants and appraisal of published phenotypes
gan: Barbara Castellotti, et al.
Cyhoeddwyd: (2023-06-01)

SEMA3B‐AS1 suppresses colorectal carcinoma progression by inhibiting Semaphorin 3B‐dependent VEGF signaling pathway activation
gan: Yi‐Qing Wang, et al.
Cyhoeddwyd: (2023-10-01)

Sema4C Is Required for Vascular and Primary Motor Neuronal Patterning in Zebrafish
gan: Jiajing Sheng, et al.
Cyhoeddwyd: (2022-08-01)

Impact of leptin or melatonin on Sema4D overexpression-related bone metabolism
gan: Zhenen Lin, et al.
Cyhoeddwyd: (2023-04-01)

Increased levels of plasma soluble Sema4D in patients with heart failure.
gan: Qiongyu Lu, et al.
Cyhoeddwyd: (2013-01-01)

Architecture of the Sema3A/PlexinA4/Neuropilin tripartite complex
gan: Defen Lu, et al.
Cyhoeddwyd: (2021-05-01)

Associations of SEMA7A, SEMA4D, ADAMTS10, and ADAM8 with KRAS, NRAS, BRAF, PIK3CA, and AKT Gene Mutations, Microsatellite Instability Status, and Cytokine Expression in Colorectal Cancer Tissue
gan: Błażej Ochman, et al.
Cyhoeddwyd: (2024-09-01)

Semâ ve Devrân Hakkında İki Risâle
gan: Dilâver Gürer
Cyhoeddwyd: (2003-05-01)

Historical Portrait of Prof. Dr. Sema Kut
gan: Sema Kut
Cyhoeddwyd: (2013-12-01)

MiR-125b Suppression Inhibits Apoptosis and Negatively Regulates Sema4D in Avian Leukosis Virus-Transformed Cells
gan: Chaoqi Ren, et al.
Cyhoeddwyd: (2019-08-01)

SEMA: Antigen B-cell conformational epitope prediction using deep transfer learning
gan: Tatiana I. Shashkova, et al.
Cyhoeddwyd: (2022-09-01)

Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal Cancers.
gan: Vitaly I Loginov, et al.
Cyhoeddwyd: (2015-01-01)

Novel Truncating and Missense Variants in SEMA6B in Patients With Early-Onset Epilepsy
gan: Song Xiaozhen, et al.
Cyhoeddwyd: (2021-05-01)

LncRNA SEMA3B-AS1 inhibits breast cancer progression by targeting miR-3940/KLLN axis
gan: Jin Hu, et al.
Cyhoeddwyd: (2022-09-01)

Knockout of Sema4D alleviates liver fibrosis by suppressing AOX1 expression
gan: Lifu Wang, et al.
Cyhoeddwyd: (2023-09-01)

Beneficial effects of fingolimod in MS patients with high serum Sema4A levels.
gan: Toru Koda, et al.
Cyhoeddwyd: (2018-01-01)

Correction: Increased Levels of Plasma Soluble Sema4D in Patients with Heart Failure.
gan: Qiongyu Lu, et al.
Cyhoeddwyd: (2019-01-01)

SEMA4D compromises blood–brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease
gan: Ernest S. Smith, et al.
Cyhoeddwyd: (2015-01-01)

Clinical values of serum Semaphorin 4D (Sema4D) in medication‑related osteonecrosis of the jaw
gan: Hong Mu, et al.
Cyhoeddwyd: (2023-03-01)